HYPE climbed after a Nasdaq biotech firm struck an $888 million deal to create a new company set to hold and buy more of the token.
Source link
HYPE climbed after a Nasdaq biotech firm struck an $888 million deal to create a new company set to hold and buy more of the token.
Source link